Correlation Between Vigil Neuroscience and Actinium Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vigil Neuroscience and Actinium Pharmaceuticals, you can compare the effects of market volatilities on Vigil Neuroscience and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Actinium Pharmaceuticals.

Diversification Opportunities for Vigil Neuroscience and Actinium Pharmaceuticals

0.85

Correlation Coefficient

Vigil Neuroscience  Actinium Pharmaceuticals

Very poor diversification

The 3 months correlation between Vigil and Actinium is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Actinium Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Actinium Pharmaceuticals

Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Actinium Pharmaceuticals. In addition to that, Vigil Neuroscience is 1.06 times more volatile than Actinium Pharmaceuticals. It trades about -0.14 of its total potential returns per unit of risk. Actinium Pharmaceuticals is currently generating about -0.11 per unit of volatility. If you would invest  186.00  in Actinium Pharmaceuticals on September 13, 2024 and sell it today you would lose (58.00) from holding Actinium Pharmaceuticals or give up 31.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Vigil Neuroscience  vs.  Actinium Pharmaceuticals

Vigil Neuroscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Actinium Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Actinium Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Vigil Neuroscience and Actinium Pharmaceuticals

The main advantage of trading using opposite Vigil Neuroscience and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.

The idea behind Vigil Neuroscience and Actinium Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.